16
Feb 2021
Scotland first UK nation to approve ‘take at home’ drug for MS
The Scottish Medicines Consortium (SMC) has approved a new treatment for patients with multiple sclerosis. MS is a condition which is caused by the body’s own immune system attacking the nervous system, affecting the spinal cord and brain. Symptoms include blurred vision, difficulties with movement and cognitive impairment. The drug, Zeposia, has been developed for…

